Insights

Strong Market Presence Avicanna has established itself as a leading medical cannabis brand in Canada with nationwide availability and international expansion, creating opportunities to introduce new cannabinoid formulations to diverse healthcare markets.

Expanding Product Pipeline With an extensive pipeline of indication-specific drug candidates in dermatology, pain, and neurological disorders, there are opportunities to collaborate on clinical development, licensing, and distribution of innovative pharmaceutical cannabis products.

Strategic Partnerships Recent collaborations with Philip Morris International, Vectura Fertin Pharma, and partnerships with healthcare organizations like the Nurse Practitioners' Association of Ontario indicate a strong network for joint ventures, educational initiatives, and co-marketing efforts targeting medical professionals.

Innovative Delivery Platforms Avicanna’s diverse product formulations, including topical, oral, and transdermal cannabis products supported by ongoing education efforts, present opportunities to develop tailored delivery systems for different patient segments and medical conditions.

Financial and Growth Potential While currently generating revenue between one and ten million dollars, Avicanna’s focus on scientific research, clinical development, and emerging international markets positions it for potential growth, making it a promising partner for sales of medical cannabis and pharmaceutical products in expanding markets.

Similar companies to Avicanna Inc. (TSX:AVCN)

Avicanna Inc. (TSX:AVCN) Tech Stack

Avicanna Inc. (TSX:AVCN) uses 8 technology products and services including Vue.js, jQuery Migrate, Salesforce Marketing Cloud, and more. Explore Avicanna Inc. (TSX:AVCN)'s tech stack below.

  • Vue.js
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Salesforce Marketing Cloud
    Marketing Performance Measurement
  • Bootstrap
    UI Frameworks
  • YouTube
    Video Players
  • MailChimp for WordPress
    Web Platform Extensions
  • Apache
    Web Servers
  • bxSlider
    Web Tools And Plugins

Media & News

Avicanna Inc. (TSX:AVCN)'s Email Address Formats

Avicanna Inc. (TSX:AVCN) uses at least 1 format(s):
Avicanna Inc. (TSX:AVCN) Email FormatsExamplePercentage
First.Last@avicanna.comJohn.Doe@avicanna.com
87%
First.Middle@avicanna.comJohn.Michael@avicanna.com
10%
FirstMiddle.Last@avicanna.comJohnMichael.Doe@avicanna.com
2%
FL@avicanna.comJD@avicanna.com
1%

Frequently Asked Questions

What is Avicanna Inc. (TSX:AVCN)'s official website and social media links?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s official website is avicanna.com and has social profiles on LinkedInCrunchbase.

What is Avicanna Inc. (TSX:AVCN)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Avicanna Inc. (TSX:AVCN) have currently?

Minus sign iconPlus sign icon
As of December 2025, Avicanna Inc. (TSX:AVCN) has approximately 72 employees across 4 continents, including North AmericaSouth AmericaEurope. Key team members include Chief Executive Officer: A. A.Vice President - Operations: T. W.Vice President Commercial Operations Europe / Latam: J. K.. Explore Avicanna Inc. (TSX:AVCN)'s employee directory with LeadIQ.

What industry does Avicanna Inc. (TSX:AVCN) belong to?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN) operates in the Biotechnology Research industry.

What technology does Avicanna Inc. (TSX:AVCN) use?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s tech stack includes Vue.jsjQuery MigrateSalesforce Marketing CloudBootstrapYouTubeMailChimp for WordPressApachebxSlider.

What is Avicanna Inc. (TSX:AVCN)'s email format?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s email format typically follows the pattern of First.Last@avicanna.com. Find more Avicanna Inc. (TSX:AVCN) email formats with LeadIQ.

How much funding has Avicanna Inc. (TSX:AVCN) raised to date?

Minus sign iconPlus sign icon
As of December 2025, Avicanna Inc. (TSX:AVCN) has raised $2.1M in funding. The last funding round occurred on Aug 01, 2021 for $2.1M.

When was Avicanna Inc. (TSX:AVCN) founded?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN) was founded in 2016.

Avicanna Inc. (TSX:AVCN)

Biotechnology ResearchOntario, Canada51-200 Employees

Avicanna is a life sciences company focused on advancement and commercialization of evidence-based cannabinoid products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D & clinical development that has led to the commercialization of 30+ products across various market segments: 

•	Medical Cannabis & Wellness Products (RHO Phyto™): The formulary offers a diverse range of proprietary formulations including oral, sublingual, topical, & transdermal deliveries with varying ratios of cannabinoids and is supported with ongoing patient, and medical community education. RHO Phyto is a leading medical brand in Canada and is currently available nationwide to patients across several medical channels and continues to expand into new international markets.

•	Pharmaceutical Preparations and Pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has an extensive pipeline of indication-specific, patent-pending drug candidates in various stages of clinical development and commercialization. These drug candidates aim to address unmet medical needs in dermatology, chronic pain, and various neurological disorders. Avicanna’s first pharmaceutical preparation (Trunerox™) is approved in Colombia and is in registration in other South American markets.

•	MyMedi.ca Medical Cannabis Care: MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the patient journey. MyMedi.ca is operated by Northern Green Canada Inc., and features a diverse portfolio of products and pharmacist-led patient support programs. It also provides specialty services to distinct patient groups such as veterans and collaborates with public and private providers for adjudication and reimbursement. MyMedi.ca provides educational resources to facilitate the incorporation of medical cannabis into health care regimens.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $2.1M

    Avicanna Inc. (TSX:AVCN) has raised a total of $2.1M of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2021 in the amount of $2.1Mas a secured term loan financing.

  • $1M$10M

    Avicanna Inc. (TSX:AVCN)'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $2.1M

    Avicanna Inc. (TSX:AVCN) has raised a total of $2.1M of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2021 in the amount of $2.1Mas a secured term loan financing.

  • $1M$10M

    Avicanna Inc. (TSX:AVCN)'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.